1.Javadi M, Asgari H, Yaghoobbi M, Tavazohi H: Self-assessment of the non-communicable disease surveillance system in Medical University of Isfahan based on the model suggested by the World Health Organization. Journal of School of Public Health and Institute of Public Health Research 2010, 8(3):47–60.
2.Stats F: National Chronic Kidney Disease Fact Sheet, 2017. US Department of Health and Human Services, Centers for Disease Control and prevention; 2017.
3.Dehvan F, Monjazebi F, Khanghahi ME, Mohammadi H, Gheshlagh R, Kurdi A: Adequacy of dialysis in Iranian patients undergoing hemodialysis: a systematic review and meta-analysis. Nephro-Urology Monthly 2018, 10(5).
4.Haghighi AN, Broumand B, D’Amico M, Locatelli F, Ritz E: The epidemiology of endâ€گstage renal disease in Iran in an international perspective. Nephrology Dialysis Transplantation 2002, 17(1):28–32.
5.Glover C, Banks P, Carson A, Martin CR, Duffy T: Understanding and assessing the impact of end-stage renal disease on quality of life. The Patient: Patient-Centered Outcomes Research 2011, 4(1):19–30.
6.Brunner LS: Brunner & Suddarth’s textbook of medical-surgical nursing. Volume 1: Lippincott Williams & Wilkins; 2010.
7.Raiesifar A, Torabpour M, Mohsenizad P: Causes of chronic renal failure in hemodialysis patients of Abadan. Journal of Critical Care Nursing 2010, 2(4):11–12.
8.Burtis CA, Ashwood ER, Bruns DE: Tietz textbook of clinical chemistry and molecular diagnostics-e-book: Elsevier Health Sciences; 2012.
9.Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P: Human serum albumin: from bench to bedside. Molecular aspects of medicine 2012, 33(3):209–290.
10.Gilani N, Kazemnejad A, Zayeri F: Determining the Factors Affecting Albumin Serum in Hemodialysis Patients Using Random Effects Model. Journal of Mazandaran University of Medical Sciences 2015, 25(131):40–47.
11.Bashardoust B, Gavami M, Maleki N, Doustkami H, Habibzadeh S: Mortality and Nutritional Status in Patients Undergoing Hemodialysis. Shiraz E-Medical Journal 2015, 16(2).
12.Hashemi M, Garshad A: Assissing the Adequacy of Dialysis and some biochemical Factors related to it in patient under Heamodialysis in Dialysis ward of Emam Ali Hospital Of Bojnourd. J North Khorasan Uni Med Sci 2012, 4(4):665–670.
13.Nafar M, Samavat S, Khoshdel A, Abedi BA: Dialysis adequacy, dialyzer clearance, and strategies to achieve target: A nationwide multicenter study. Nephro-Urology Monthly 2017, 9(1).
14.Biniaz V, Moonaghi HK, Froutan R, Ebadi A: Kt/V: A Magical Formula for Dialysis Adequacy: A Critical Review. Jundishapur Journal of Chronic Disease Care 2017, 6(4).
15.Rezaiee O, Shahgholian N, Shahidi S: Assessment of hemodialysis adequacy and its relationship with individual and personal factors. Iranian journal of nursing and midwifery research 2016, 21(6):577.
16.Schober P, Vetter TR: Survival analysis and interpretation of time-to-event data: the tortoise and the hare. Anesthesia and analgesia 2018, 127(3):792.
17.Peduzzi P, Concato J, Feinstein AR, Holford TR: Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. Journal of clinical epidemiology 1995, 48(12):1503–1510.
18.Harrell Jr FE: Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis: Springer; 2015.
19.Tibshirani RJ, Taylor J: Degrees of freedom in lasso problems. The Annals of Statistics 2012, 40(2):1198–1232.
20.Foley RN, Collins AJ: End-stage renal disease in the United States: an update from the United States Renal Data System. Journal of the American Society of Nephrology 2007, 18(10):2644–2648.
21.Schroijen MA, van de Luijtgaarden MWM, Noordzij M, Ravani P, Jarraya F, Collart F, Prأ¼tz KG, Fogarty DG, Leivestad T, Prischl FC: Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia 2011, 56(9):1949–1957.
22.Andrianesis V, Doupis J: The role of kidney in glucose homeostasis—SGLT2 inhibitors, a new approach in diabetes treatment. Expert review of clinical pharmacology 2013, 6(5):519–539.
23.Zhang A-H, Cheng L-T, Zhu N, Sun L-H, Wang T: Comparison of quality of life and causes of hospitalization between hemodialysis and peritoneal dialysis patients in China. Health and quality of life outcomes 2007, 5(1):49.
24.Aoyagi T, Naka H, Miyaji K, Hayakawa K, Ishikawa H, Hata M: Body mass index for chronic hemodialysis patients: stable hemodialysis and mortality. International Journal of Urology 2001, 8(8).
25.Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. American journal of kidney diseases 2001, 38(6):1251–1263.
26.Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, Boudville N, Polkinghorne KR, McDonald SP, Johnson DW: The association between body mass index and mortality in incident dialysis patients. PloS one 2014, 9(12):e114897.
27.Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Cruess DF, Kimmel PL: Body mass index, dialysis modality, and survival: analysis of the United States renal data system dialysis morbidity and mortality wave II study. Kidney international 2004, 65(2):597–605.
28.Lopes AA, Bragg-Gresham JL, Goodkin DA, Fukuhara S, Mapes DL, Young EW, Gillespie BW, Akizawa T, Greenwood RN, Andreucci VE: Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Quality of life research 2007, 16(4):545–557.
29.Rafiee Vardanjani L, Parvin N, Shan M, Reza G, Molaie E, Shariati A, Hasheminia MA: Adherence to hemodialysis treatment and some related factors in hemodialysis patients admitted in Shahrekord Hajar hospital. Journal of Clinical Nursing and Midwifery 2014, 2(4):17–25.
30.Takeda A, Toda T, Shinohara S, Mogi Y, Matsui N: Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin. American journal of kidney diseases 2002, 40(1):104–109.
31.Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. Journal of the American Society of Nephrology 2002, 13(4):1061–1066.
32.Mogharab M, Rezaee N, Tahouri F, Taheri P, Jani H: Complications during hemodialysis in chronic hemodialysis patients using dialysis buffer solution with sodium acetate and sodium bicarbonate. Modern Care Journal 2007, 4(1):21–28.